How Chronic Inflammation Triggers Malignant Transformation and Progression

92 concepts76 papers3 proposals

For decades, inflammation was viewed primarily as the body’s localized defense mechanism against injury or infection—a temporary physiological alarm system that recedes once healing is complete. However, a profound shift in oncology has revealed that when this alarm system fails to turn off, chronic inflammation transitions from a protective response into an active driver of oncogenesis.

Rather than being a passive byproduct of tumor growth, persistent inflammatory environments function as an "ignition switch" and fuel source for cancer. This process operates through a series of highly coordinated molecular bridges, cellular reprogramming events, and microenvironmental modifications that collectively transform healthy or damaged tissue into a malignant state.

The Intracellular Engines: NF-κB and the Inflammasome

To understand why chronic inflammation drives cancer, we must look at how persistent inflammatory signaling alters the internal survival circuitry of the cell. In a healthy state, cells undergo apoptosis (programmed cell death) when they accumulate severe DNA damage. Chronic inflammation overrides this safety brake.

A central pathway in this survival shift is the NF-κB signaling cascade. Under normal conditions, NF-κB subunits like p65 are tightly regulated and degraded when no longer needed. However, in inflammatory environments, this pathway becomes chronically stabilized. For instance, Jun Liu et al. demonstrated that in hepatitis B virus-associated hepatocellular carcinoma, the proteins SUMO2/3 physically interact with and stabilize p65 within the cytoplasm. By preventing its proteasomal degradation, the cell maintains a continuous stream of NF-κB activation.

This sustained activation directly alters cell fate. When pathogens or environmental stressors trigger long-term NF-κB signaling—such as during chronic Enterococcus faecalis colonization as explored by Jesper A.B. Strickertsson et al.—the result is a surge in pro-survival cytokines and the upregulation of anti-apoptotic proteins like survivin (Jun Yu et al.). Cells that should die instead survive, replicating their damaged DNA and initiating the first steps toward malignancy.

Parallel to NF-κB is the chronic activation of intracellular protein complexes known as inflammasomes, particularly the NLRP3 inflammasome. As reviewed by Xiangda Meng et al., persistent tissue damage keeps the NLRP3 pathway active, generating a continuous supply of pro-inflammatory cytokines that sustain a pro-tumorigenic niche. This pathway is so critical to tumor maintenance that targeting it—for example, via liposomal delivery of natural compounds to suppress the TLR4/NLRP3 axis as shown by Chunxia Chen et al.—can effectively halt tumor progression and restore anti-tumor immunity.

Cytokine Signaling Axes and Epigenetic Reprogramming

Beyond keeping damaged cells alive, chronic inflammation actively rewrites a cell's identity. This is driven by specific extracellular cytokines that bind to surface receptors and trigger intracellular kinase cascades, ultimately altering gene transcription.

The Interleukin-6 (IL-6) family stands out as a primary mediator of this transformation. When IL-6 binds to its receptor complex, which includes the signaling component glycoprotein 130 (gp130) (Yifan Cao et al.), it activates the JAK2/STAT3 pathway. This axis acts as a direct molecular bridge between the extracellular inflammatory environment and oncogenic gene expression.

[Extracellular IL-6] ➔ [gp130 / JAK2 Activation] ➔ [STAT3 Phosphorylation] ➔ [Transcriptional Reprogramming]

This signaling does not just accelerate growth; it fundamentally alters the cell's differentiation state. Tingyang Wang et al. uncovered a precise mechanism where IL-6 induces the deacetylation of the transcription factor FRA1. This chemical modification changes how FRA1 interacts with DNA, directly reprogramming colorectal cancer cells into a self-renewing, stem-like state.

Furthermore, these cytokine pathways frequently intersect with other developmental cascades. Xiaoxia Zeng et al. traced how the transcription factor SPZ1 drives nasopharyngeal carcinoma by activating a Wnt5a/IL-6 signaling loop, while Xiaotian Han et al. showed that oncogenes like NPTX2 exploit the IL6-JAK2/STAT3 pathway to fuel ovarian cancer progression under hypoxic conditions. The downstream effects can even loop back to amplify the inflammatory state: Xiao Li et al. demonstrated that IL-6-mediated JAK2/STAT3 signaling upregulates the transcription factor Sox4, which directly reactivates the NLRP3 inflammasome, creating a self-sustaining loop of hyper-inflammation and malignant growth.

Remodeling the Microenvironment for Metastasis

For a tumor to progress and metastasize, it must reshape its surrounding tissue architecture. Chronic inflammation facilitates this by subverting immune cells into agents of tissue remodeling and immune evasion.

In the context of colitis-associated cancer, the transition from chronic tissue irritation to overt malignancy relies heavily on the recruitment of specific immune populations. Yunben Yang et al. mapped a cellular relay where gut dysbiosis prompts the recruitment of monocyte-like macrophages to the colon. These macrophages secrete Interleukin-1β (IL-1β), which activates Th17 cells, driving the rapid cell division and structural tissue remodeling required for early tumorigenesis. Similarly, the secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) drives the accumulation of myeloid-derived suppressor cells (MDSCs), effectively blinding the adaptive immune system to the emerging threat (Ning Ma et al.).

Inflammatory signals also polarize existing immune cells from defenders into co-conspirators. For example, Fengxian Qin et al. demonstrated that high levels of TGF-β within the colorectal tumor microenvironment polarize tumor-associated neutrophils (TANs) into a pro-tumor (N2) phenotype. Inhibiting TGF-β reverts these cells into an anti-tumor (N1) state, underscoring how plastic the microenvironment remains under the influence of inflammatory cues.

Crucially, this inflammatory remodeling is not restricted to the primary tumor site. Systemic inflammation alters physiology at a organismal level, preparing distant organs for metastatic colonization:

  • Distant Organ Susceptibility: Using Mendelian randomization, Hui Gao et al. established a causal link between localized inflammatory bowel disease and extracolonic malignancies, driven by systemic inflammatory mediators that downregulate protective proteins in distant tissues like breast tissue.
  • Pre-Metastatic Niches: Xinyang Chen et al. showed that systemic inflammatory markers and clotting factors actively facilitate a physiological environment that promotes prostate cancer cell migration and colonization in bone tissue, effectively creating a fertile "soil" for metastatic "seeds."

Upstream Initiators: What Starts the Fire?

If chronic inflammation is the engine of this oncogenic transformation, what acts as the spark? The source material points to a diverse array of biological, physical, and environmental triggers that all converge on the same inflammatory pathways.

Long-term parasitic and bacterial infections are classic biological initiators. In liver oncology, Shuyan Sheng et al. identified that chronic infection by the parasite Schistosoma japonicum forces the upregulation of the Polycomb group protein BMI1. This protein serves as a direct molecular bridge, translating decades of parasitic tissue irritation into the uncontrolled proliferation and invasion characteristic of hepatocarcinogenesis.

Physical and environmental stressors can be equally oncogenic. In a historical analysis of heat-induced skin cancers, Ernesto Damiani illustrated how chronic localized hyperthermia acts as a potent tumor promoter. Unlike ultraviolet radiation, which directly mutates DNA, chronic heat initiates a persistent inflammatory response that permits the expression and expansion of existing, latent genetic damage.

Even systemic behavioral and psychological states can initiate this cascade. Wanqing Li reviewed evidence showing that chronic psychological stress disrupts gut microbiota and intestinal motility. This microbial dysbiosis leads to the accumulation of toxic metabolic byproducts, damaging the epithelial lining and triggering the very chronic inflammatory cascades that culminate in colorectal cancer.

Ultimately, whether the initial insult is a chronic parasitic infection, a disrupted gut microbiome, or a persistent physical stressor, the destination remains remarkably consistent. By subverting homeostatic pathways like NF-κB and IL-6/STAT3, chronic inflammation systematically dismantles cellular safety mechanisms, rewrites the transcriptome, and remodels the microenvironment—turning the body's primary healing mechanism into a powerful engine for cancer growth.

Key Foundational Work

Increased expression of survivin in gastric cancer patients and in first degree relatives (2002) — contributed 1 concept elements to this direction.
History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_inflammation_driven_oncogenesis_52d5bb0b,
  title = {inflammation-driven oncogenesis},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/inflammation-driven-oncogenesis/rdr_52d5bb0b64e84c04bea9b3e04718e98b},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}

This exact version (version 1, frozen text):

@misc{lacuna_inflammation_driven_oncogenesis_52d5bb0b_v1,
  title = {inflammation-driven oncogenesis},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/inflammation-driven-oncogenesis/rdr_52d5bb0b64e84c04bea9b3e04718e98b/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake